André van de Sande

General Manager, Europe

André van de Sande is a senior executive with 30 years of Life Sciences experience in both mature and emerging markets in Western and Central Europe, Asia Pacific, and Middle East Africa. He has successfully managed the country and regional teams of up to 1100 employees and a turnover of €350 million with Organon International and Schering-Plough Corporation. André has non-executive and advisory board experience with a.o. Lloyds Pharmacies and as chairman of the Dutch Biotech Association BioFarmind (now HollandBio). André has been leading Xendo since 2011. He holds an MBA degree from Tilburg University in The Netherlands, an MSc in Management from Purdue University in the United States, and also completed the supervisory board member program of Nyenrode University. André is fluent in Dutch, English, and German with a working knowledge of French and Hungarian.

Company Blog

November 29, 2018
Industry Poll: How Can Your GMP Auditing Program Be Most…
Expert insight into how you can take steps to best improve your GMP auditing… Read More
November 15, 2018
The Important Role of Advanced Therapy Medicinal Products
Today on the blog, a personal perspective from a colleague on the impact and… Read More
October 16, 2018
Outdated Facilities – Bring Back the ‘c’ in cGMP
Bringing the ‘c’ in the cGMP status back into your facility, processes, or procedures… Read More
More Articles


January 28, 2019
DIA Pharmacovigilance and Risk Management Strategies Conference
Join us at DIA’s Pharmacovigilance and Risk Management Strategies Conference for context, background,... Read More
February 18, 2019
SCOPE – Summit for Clinical Ops Executives
SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-de... Read More
March 18, 2019
DIA Medical Affairs and Scientific Communications
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us